Researchers mark milestone in progress toward investigational new drug for triple-negative breast cancer
by Leslie Cantu,Medical University of South CarolinaDr. Ozgur Sahin, center, with first authors Drs. Ozge Saatci and Metin Cetin. Credit: MUSC Hollings Cancer CenterA new compound developed by r
Updated on: August 01,2024
0

Researchers mark milestone in progress toward investigational new drug for triple-negative breast cancer
by Leslie Cantu,Medical University of South CarolinaDr. Ozgur Sahin, center, with first authors Drs. Ozge Saatci and Metin Cetin. Credit: MUSC Hollings Cancer CenterA new compound developed by r
Updated on:August 01,2024
0
